Pharmalittle: Antibiotic shortages putting patients at risk; EMA fears staff losses as HQ move nears

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is moderately interesting. We plan to escort Mrs. Pharmalot to a cultural , putter around the castle, and catch up on napping. And what about you? Once again, we will note this is a lovely time of year to enjoy the great outdoors. In fact, you could plan a summer getaway. You could curl up with a nice e-book, reach out to someone special or simply plan the rest of your life. But if indulging on social

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Solid Biosciences’ Duchenne Gene Therapy Trial Halted After Patient Suffers Serious Toxicity
The FDA has halted a clinical trial involving a Duchenne muscular dystrophy gene therapy from Solid Biosciences after a patient suffered serious kidney and blood-related injuries.
STAT10 min readTech
It’s Tiny Biotechs — Not Big Drug Makers — That Fear ‘Nuclear Winter’ From Pelosi’s Drug Pricing Bill
Washington hasn’t spent much time considering how small biotech companies will fare under Pelosi’s drug pricing bill — but CEOs said they predict a “devastating effect” on investment.
STAT4 min read
Opinion: Diabetic Foot Ulcers: A Silent Killer Of Veterans
The VA is a pioneer when it comes to detecting and treating diabetic foot ulcers and their complications. But it, and the NIH, need to invest more in research on…